Detalhe da pesquisa
1.
Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial.
Circulation
; 143(22): 2155-2165, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33823606
2.
Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention: The SORT OUT IX Trial.
Circulation
; 141(25): 2052-2063, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32434381
3.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial.
Lancet
; 395(10219): 191-199, 2020 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31879028
4.
Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy.
Cardiology
; 146(4): 409-418, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849035
5.
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
Eur Heart J
; 41(7): 847-854, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31504424
6.
Lower ST-elevation myocardial infarction incidence during COVID-19 epidemic in Northern Europe.
Scand Cardiovasc J
; 54(6): 358-360, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32945201
7.
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.
Lancet
; 388(10061): 2743-2752, 2016 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27810312
8.
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
Am Heart J
; 190: 54-63, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760214
9.
Chronic total coronary occlusion: treatment results.
Scand Cardiovasc J
; 51(4): 197-201, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28425767
10.
Coronary bifurcation lesions treated with simple or complex stenting: 5-year survival from patient-level pooled analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study.
Eur Heart J
; 37(24): 1923-8, 2016 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27161619
11.
Zotarolimus-eluting durable-polymer-coated stent versus a biolimus-eluting biodegradable-polymer-coated stent in unselected patients undergoing percutaneous coronary intervention (SORT OUT VI): a randomised non-inferiority trial.
Lancet
; 385(9977): 1527-35, 2015 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601789
12.
Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
Lancet
; 383(9934): 2047-2056, 2014 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-24631162
13.
Influence of multivessel disease with or without additional revascularization on mortality in patients with ST-segment elevation myocardial infarction.
Am Heart J
; 170(1): 70-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26093866
14.
Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials.
J Thromb Thrombolysis
; 39(1): 101-12, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24968748
15.
Biolimus-eluting biodegradable polymer-coated stent versus durable polymer-coated sirolimus-eluting stent in unselected patients receiving percutaneous coronary intervention (SORT OUT V): a randomised non-inferiority trial.
Lancet
; 381(9867): 661-9, 2013 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23374649
16.
Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
Catheter Cardiovasc Interv
; 83(6): 864-72, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23996918
17.
Long-term outcome following percutaneous coronary intervention with drug-eluting stents compared with bare-metal stents in saphenous vein graft lesions: from Western Denmark Heart Registry.
Catheter Cardiovasc Interv
; 83(7): 1035-42, 2014 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24311384
18.
Clopidogrel discontinuation within the first year after coronary drug-eluting stent implantation: an observational study.
BMC Cardiovasc Disord
; 14: 100, 2014 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-25125079
19.
Similar five-year outcome with paclitaxel- and sirolimus-eluting coronary stents.
Scand Cardiovasc J
; 48(3): 148-55, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24548278
20.
Randomized study to assess the effect of thrombus aspiration on flow area in patients with ST-elevation myocardial infarction: an optical frequency domain imaging study--TROFI trial.
Eur Heart J
; 34(14): 1050-60, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23396493